Table 1.
Training | Validation | p | ||
---|---|---|---|---|
Age | 44.06 ± 14.00 | 49.76 ± 13.44 | 0.040399 * | |
Gender | Male | 26 | 23 | 0.088934 |
Female | 37 | 19 | ||
Histology | Astrocytoma | 21 | 11 | 0.127063 |
Oligoastrocytoma | 18 | 10 | ||
Oligodendroglioma | 24 | 21 | ||
Grade | II | 26 | 20 | 0.262543 |
III | 37 | 22 | ||
Subtype | Classic-like | 2 | 3 | 0.09987 |
Codel | 13 | 15 | ||
G-CIMP-high | 38 | 16 | ||
G-CIMP-low | 2 | |||
Mesenchymal-like | 6 | 7 | ||
PA-like | 2 | 1 | ||
Vital status | Dead | 13 | 13 | 0.117054 |
Alive | 29 | 50 | ||
IDH status | Mutant | 53 | 31 | 0.099583 |
Wildtype | 10 | 11 | ||
1p_19q codeletion status | Codel | 13 | 14 | 0.073916 |
Non-codel | 50 | 28 | ||
MGMT promoter status | Methylated | 51 | 39 | 0.045106 * |
Unmethylated | 12 | 3 | ||
TMB group | TMB high | 25 | 18 | 0.37498 |
TMB low | 38 | 24 |
* statistically significant with p < 0.05.